Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Challenges in Transitioning from Methadone to Buprenorphine- Naloxone for Chronic Pain Management: Two Cases
1
x
$
30.00
Opciones fármacoterapéuticas en el tratamiento de la depresión y ansiedad comórbidas
1
x
$
0.00
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
1
x
$
30.00
View Cart
Checkout
Home
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
“Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine” has been added to your cart.
View cart
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 4 Articles
Tags:
cholesterol
,
david-c-steffens
,
depression
,
douglas-r-mcquoid
,
elderly
,
k-ranga-rama-krishnan
,
medication
,
relapse
,
vascular
Description
Description
David C. Steffens, MD, MHS
PSYCHIATRIC COMORBIDITIES
Cholesterol-Lowering Medication and Relapse of Depression
David C. Steffens, MD, MHS, Douglas R. McQuoid, BS, and K. Ranga Rama Krishnan, MB, ChB
Related products
Efficacy of Omega-3 Fatty Acids in Mood Disorders
$
30.00
Add to cart
Details
Remission as the Critical Outcome of Depression Treatment
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Page load link
Go to Top
